Close Menu

NIH

Blocked Entry

NIH Director Francis Collins apologizes for security blocking two Iranian researchers from the agency campus, according to the Washington Post.

The funding will enable the Institute for Genome Sciences to pursue a number of infectious disease research initiatives using omics technologies.

The effort, outlined in a Development Cell paper published online today, aims to complement the ongoing Human Cell Atlas initiative, but with a focus on pediatric health.

The Telomere-to-Telomere consortium has already generated a gapless assembly of the human X chromosome and aims to complete all chromosomes over the next two years or so.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

In PLOS this week: computational strategy for improving gene set analysis testing, miRNAs linked to sleep apnea, and more.

Us Research Program to Test Options for Returning Results

The program's participant center at the Scripps Research Translational Institute is planning to test different modules for returning results.

Eighteen researchers call for a temporary stop to all clinical uses of human germline editing in a piece appearing in Nature.

A statement from NIH Director Francis Collins follows a call by scientists for the moratorium pending the creation of a framework to guide the use of heritable genome editing.

The Trump Administration's budget proposal for fiscal year 2020 includes a 12 percent cut to National Institutes of Health funding.

Pages

According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.

An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.

US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.

In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.